Innovation in health systems
The latest PharmaFutures dialogue extends the analysis of its more recent report, opening up the conversation to include payers, regulators and other societal and government experts as well as assessing new trends in reimbursement, innovation and productivity.
Run over two years, the dialogue will explore the impact on healthcare of long-term trends such as ageing, chronic diseases, risk and inequality, as well as reviewing the impact of the current economic and financial turmoil. Looking at Europe, Emerging Markets, the US and then the global market, it will explore where these trends might lead and the circumstances under which healthcare innovation can be harnessed to improve productivity and efficiency. The aim is to support informed investment decision-making and to encourage management practices that enhance the industry’s relationship with societal stakeholders.
Comments
I hope to engage in a constructive dialogue as I look for profitable and sustainable business models of sufficient scope and scale for pharmaceutical companies expanding their business into developing countries.
Martin Eijgenhuijsen, APG